Thakur Susmita, Rana Rishabh Kumar, Kumari Mona, Jha Ravi R, Bhushan Rabi, Verma Raj Kishore
Department of Community Medicine, Shaheed Nirmal Mahto Medical College and Hospital, Dhanbad, Jharkhand, India.
Department of Pharmacology, Shaheed Nirmal Mahto Medical College and Hospital, Dhanbad, Jharkhand, India.
J Family Med Prim Care. 2021 Dec;10(12):4578-4585. doi: 10.4103/jfmpc.jfmpc_1143_21. Epub 2021 Dec 27.
India intends to start its 1 dose of vaccination against Covid-19 on January 16, 2021 prioritizing its frontline health care professionals with either of the two vaccines-Covaxin or Covishield. Whenever a new vaccine is launched, it is marred with controversy and myths. To understand the doubts and concerns better, this study was conducted on health care professionals working in a tertiary care hospital.
Willing respondents, who are working in the institute, were administered the questionnaire asking their views on knowledge, beliefs, and reasons for hesitancy regarding Covid-19 immunization. A Likert scale was used to quantify the responses regarding participants' knowledge, beliefs, and hesitancies regarding immunization with the available vaccines. Data were analyzed using MS office Excel sheets and JASP software was used to analyze the data thus obtained.
Out of 122 complete responses, we had 73 (60%) doctors, while 30 (24%) were nursing staff, the rest comprised of other health care workers, such as housekeeping staff, janitorial, etc., 66 (54%) respondents were unaware, while 25 (20%) respondents had hesitancy and 23 (18%) were having extremely negative views regarding vaccination. Some of the variables, such as age, role, marital status, gender, etc., were found to be possibly associated with these scores.
Issues like concerns over vaccine safety, efficacy, reliability, etc., are deterrents for individuals and whole programme and vaccination drive across the nation. Time and again it has been seen that despite the vaccines' contribution in breaking the transmission, concerns are making people either hesitant or unmotivated to get the vaccines. More dialogues from the authorities regarding the issues of concern may pave the way for more motivation to accept vaccination and increase the vaccination coverage.
印度计划于2021年1月16日开始接种一剂新冠疫苗,优先为一线医护人员接种两种疫苗之一——科瓦克辛(Covaxin)或科维希德(Covishield)。每当一种新疫苗推出时,总会伴随着争议和谣言。为了更好地了解疑问和担忧,本研究针对一家三级医院的医护人员展开。
向该机构中愿意参与的受访者发放问卷,询问他们对新冠疫苗接种的知识、信念以及犹豫的原因。采用李克特量表对参与者关于现有疫苗接种的知识、信念和犹豫程度的回答进行量化。使用微软办公软件Excel工作表分析数据,并使用JASP软件对所得数据进行分析。
在122份完整回复中,有73名(60%)医生,30名(24%)是护理人员,其余包括其他医护人员,如保洁人员、勤杂工等。66名(54%)受访者不知情,25名(20%)受访者持犹豫态度,23名(18%)对疫苗接种持极端负面看法。发现一些变量,如年龄、角色、婚姻状况、性别等,可能与这些得分有关。
对疫苗安全性、有效性、可靠性等的担忧等问题,对个人以及整个国家的疫苗接种计划和接种行动构成了阻碍。人们多次看到,尽管疫苗在阻断传播方面发挥了作用,但这些担忧使人们对接种疫苗犹豫不决或缺乏积极性。当局就相关问题进行更多对话,可能会为人们更积极地接受疫苗接种并提高接种覆盖率铺平道路。